David E. Lazar

Insider Reports History

Location
Panama City
Signature
/s/ David E. Lazar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David E. Lazar:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovaBay Pharmaceuticals, Inc. 10%+ Owner Common Stock 6,388,000 $36,028,320 $5.64 21 Oct 2025 Direct
MINIM, INC. Director, 10%+ Owner Common Stock 2,681,980 $4,049,790 $1.51 18 Feb 2025 Direct
MINIM, INC. Director, 10%+ Owner Series A Convertible Preferred Stock 85,910 $3,227,500 $1.40 18 Feb 2025 Direct
Sow Good Inc. Director Series AA Preferred Stock 1,090,000 $3,000,000 $2.00 31 Dec 2025 Direct
Sow Good Inc. Director Common Stock 5,740,000 $1,975,134 $0.3441 31 Mar 2026 Direct
TITAN PHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 100,000 $123,000 $1.23 26 Jul 2023 Direct
LQR House Inc. President, Director Common Stock 100,000 $99,000 $0.9900 02 Apr 2025 Direct
OPGEN INC Chief Executive Officer, Director, 10%+ Owner Common Stock 100,000 $85,000 $0.8500 11 Apr 2024 Direct
Cyclacel Pharmaceuticals, Inc. 10%+ Owner Common Stock 155,838 $49,868 $0.3200 30 Jul 2025 Direct
Aterian, Inc. Director Common Stock 0 $0 $0.5714 27 Apr 2026 Direct
Indaptus Therapeutics, Inc. Director Common Stock 0 $0 $2.23 22 Dec 2025 Direct
KALA BIO, Inc. Chief Executive Officer, Director Common Stock 0 $0 $0.9100 18 Dec 2025 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Ordinary Shares 0 $0 $0.4740 22 Apr 2026 Direct
OPGEN INC Chief Executive Officer, Director, 10%+ Owner Series E Convertible Preferred Stock 0 $0 $1.00 30 Jul 2024 Direct
Aterian, Inc. Director Series AA Convertible Non-Redeemable Preferred Stock 1,750,000 27 Apr 2026 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Series A Preferred Shares 1,000,000 13 Feb 2026 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Series B Preferred Shares 1,000,000 13 Feb 2026 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Series C Preferred Shares 1,000,000 13 Feb 2026 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Series D Preferred Shares 1,000,000 22 Apr 2026 Direct
MAINZ BIOMED N.V. Chief Executive Officer, Director, 10%+ Owner Series E Preferred Shares 1,000,000 22 Apr 2026 Direct
KALA BIO, Inc. Chief Executive Officer, Director Series AA Convertible Preferred Stock 900,000 24 Nov 2025 Direct
Cyclacel Pharmaceuticals, Inc. 10%+ Owner Series D Convertible Preferred Stock 354,738 26 Feb 2025 Direct
Indaptus Therapeutics, Inc. Director Series AA Convertible Non-Redeemable Preferred Stock 103,200 23 Mar 2026 Direct
Cyclacel Pharmaceuticals, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 26 Feb 2025 Direct
Indaptus Therapeutics, Inc. Director Series AAA Convertible Non-Redeemable Preferred Stock 0 23 Mar 2026 Direct
KALA BIO, Inc. Chief Executive Officer, Director Convertible Loan 0 18 Dec 2025 Direct
MINIM, INC. Director, 10%+ Owner Warrants 0 18 Feb 2025 Direct
NovaBay Pharmaceuticals, Inc. 10%+ Owner Series D Convertible Preferred Stock 0 21 Oct 2025 Direct

Insider Reports Filed by David E. Lazar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATER Aterian, Inc. 27 Apr 2026 1 $0 4 Director 01 May 2026, 17:25
ATER Aterian, Inc. 27 Apr 2026 0 $0 3 Director 01 May 2026, 17:21
QUCY Quantum Cyber N.V. 22 Apr 2026 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 28 Apr 2026, 17:39
SOWG Sow Good Inc. 31 Mar 2026 2 $0 4 Director 02 Apr 2026, 17:22
INDP Indaptus Therapeutics, Inc. 23 Mar 2026 2 $0 4 Director 24 Mar 2026, 16:02
MYNZ MAINZ BIOMED N.V. 13 Feb 2026 3 $0 4 Director 03 Mar 2026, 10:13
MYNZ MAINZ BIOMED N.V. 13 Feb 2026 0 $0 3 Director 03 Mar 2026, 10:10
SOWG Sow Good Inc. 31 Dec 2025 1 +$3,000,000 4 Chief Executive Officer, Director 05 Jan 2026, 21:33
SOWG Sow Good Inc. 31 Dec 2025 0 $0 3 Director 05 Jan 2026, 21:30
INDP Indaptus Therapeutics, Inc. 22 Dec 2025 0 $0 3 Co-Chief Executive Officer 23 Dec 2025, 19:06
KALA KALA BIO, Inc. 18 Dec 2025 1 $0 4 Chief Executive Officer, Director 22 Dec 2025, 17:18
KALA KALA BIO, Inc. 24 Nov 2025 1 $0 4 Chief Executive Officer, Director 26 Nov 2025, 15:03
KALA KALA BIO, Inc. 24 Nov 2025 0 $0 3 Chief Executive Officer, Director 26 Nov 2025, 14:50
KALA KALA BIO, Inc. 23 Nov 2025 0 $0 3/A Chief Executive Officer, Director 02 Dec 2025, 06:30
NBY NovaBay Pharmaceuticals, Inc. 21 Oct 2025 2 $0 4 10%+ Owner 29 Jan 2026, 19:30
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 1 $0 4 10%+ Owner 17 Oct 2025, 17:28
NBY NovaBay Pharmaceuticals, Inc. 19 Aug 2025 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 26 Aug 2025, 16:18
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jul 2025 1 -$83,430 4 10%+ Owner 04 Aug 2025, 19:23
YHC LQR House Inc. 02 Apr 2025 1 $0 4 President, Director 07 Apr 2025, 19:11
CYCC Cyclacel Pharmaceuticals, Inc. 26 Feb 2025 5 -$5,507,996 4 Interim CEO, 10%+ Owner 28 Feb 2025, 16:48
MINM FiEE, Inc. 18 Feb 2025 3 $0 4 Director, 10%+ Owner 10 Mar 2025, 17:35
CYCC Cyclacel Pharmaceuticals, Inc. 06 Feb 2025 1 $0 4 Interim CEO, 10%+ Owner 10 Feb 2025, 17:45
CYCC Cyclacel Pharmaceuticals, Inc. 02 Jan 2025 0 $0 3 Chief Executive Officer, Director 07 Jan 2025, 19:04
MINM MINIM, INC. 26 Dec 2024 1 +$49,974 4 Director, 10%+ Owner 31 Dec 2024, 15:57
YHC LQR House Inc. 21 Nov 2024 2 $0 4 President, Director 25 Nov 2024, 16:45
MINM MINIM, INC. 21 Oct 2024 1 $0 4 Director, 10%+ Owner 22 Oct 2024, 19:03
YHC LQR House Inc. 15 Oct 2024 0 $0 3 President, Director, 10%+ Owner 21 Oct 2024, 21:56
OPGN OPGEN INC 30 Jul 2024 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 01 Aug 2024, 17:25
/report/000141588924013032-lazar-david-e-2024-05-07 Tracon Pharmaceuticals, Inc. 07 May 2024 0 $0 3 Chief Business Dev Officer 13 May 2024, 17:00
OPGN OPGEN INC 23 Apr 2024 1 +$150,000 4/A Chief Executive Officer, Director, 10%+ Owner 01 Aug 2024, 12:26
OPGN OPGEN INC 23 Apr 2024 1 +$150,000 4 Chief Executive Officer, Director, 10%+ Owner 25 Apr 2024, 16:59
OPGN OPGEN INC 11 Apr 2024 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 12 Apr 2024, 17:03
OPGN OPGEN INC 05 Apr 2024 1 +$200,000 4/A Chief Executive Officer, Director, 10%+ Owner 31 Jul 2024, 19:05
OPGN OPGEN INC 05 Apr 2024 1 +$200,000 4 Chief Executive Officer, Director, 10%+ Owner 08 Apr 2024, 16:06
OPGN OPGEN INC 25 Mar 2024 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 03 Apr 2024, 09:13
MINM MINIM, INC. 29 Jan 2024 2 +$2,800,000 4 Director, 10%+ Owner 31 Jan 2024, 18:02
MINM MINIM, INC. 22 Jan 2024 1 $0 4 Director 24 Jan 2024, 17:10
MINM MINIM, INC. 29 Dec 2023 0 $0 3 Director 04 Jan 2024, 13:05
TTNP TITAN PHARMACEUTICALS INC 26 Jul 2023 1 $0 4 Chief Executive Officer, Director 31 Jul 2023, 19:39
TTNP TITAN PHARMACEUTICALS INC 21 Jun 2023 2 -$4,610,001 4/A Chief Executive Officer, Director, 10%+ Owner 28 Jun 2023, 16:14
TTNP TITAN PHARMACEUTICALS INC 24 Jan 2023 2 +$56,287 4 Chief Executive Officer, Director, 10%+ Owner 26 Jan 2023, 12:05
TTNP TITAN PHARMACEUTICALS INC 06 Jul 2022 3 +$1,922,882 4 10%+ Owner 08 Jul 2022, 18:00
TTNP TITAN PHARMACEUTICALS INC 06 Jul 2022 0 $0 3 10%+ Owner 08 Jul 2022, 18:00
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .